Podcast: Play in new window | Download (13.3MB)
In episode 59, the fifth podcast in our diatribe on type-2 diabetes, we finally get to the evidence surrounding specific treatments. The importance of lifestyle is discussed and then the rest of the time is spent talking about the who, what, why, where, and when’s of metformin. James asks lots of rhetorical questions and Mike tries to answer them in a grandiloquent way.
Show Notes
1) UKPDS (original trial)
2) UKPDS (recent results)
3) Metformin’s contraindications should be contraindicated
You must log in to post a comment.